Related Experiment Video

Updated: Jun 1, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Methodological aspects of phase-I studies of novel anticancer agents (review)

J Cassidy1, D Bissett, D Kerr

  • 1QUEEN ELIZABETH HOSP,DEPT CLIN ONCOL,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND.

International Journal of Oncology
|May 18, 2011
PubMed

Insights

This review summarizes 14 phase I clinical trials of anti-cancer agents conducted over 5 years. Based on experience with novel drugs and drug delivery, guidelines for future cancer research are proposed.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • Over the past 5 years, 14 phase I clinical studies were conducted.
  • Eight trials focused on novel anti-cancer agents' clinical and pharmacokinetic profiles.
  • Other trials explored drug delivery, targeting, and resistance modification for existing anti-cancer drugs.

Purpose of the Study:

  • To review the department's experience in phase I clinical trials.
  • To propose evidence-based guidelines for future cancer drug studies.
  • To inform the design and execution of upcoming clinical trials.

Main Methods:

  • Retrospective analysis of 14 phase I clinical studies.
  • Inclusion of data on novel anti-cancer agents and existing drug modifications.
  • Synthesis of clinical and pharmacokinetic data from over 200 patients.

Main Results:

  • Successful completion of 14 phase I studies within 5 years.
  • Comprehensive data gathered on novel anti-cancer agents' behavior.
  • Insights gained into drug delivery, targeting, and resistance mechanisms.

Conclusions:

  • The department has significant experience in phase I oncology trials.
  • Experience provides a basis for developing guidelines for future studies.
  • Proposed guidelines aim to enhance the efficiency and success of cancer research.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...